OptiBiotix Health (OPTI) News Today → New York goes dark, then America. (From Porter & Company) (Ad) Free OPTI Stock Alerts GBX 18 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 7, 2024 | msn.comWarning signs of an unhealthy gut and how to improve itMay 3, 2024 | americanbankingnews.comOptiBiotix Health (LON:OPTI) Share Price Crosses Below Fifty Day Moving Average of $21.42April 24, 2024 | forbes.com5 Best Stair Lifts Of 2024April 3, 2024 | forbes.comBest Protein Powders Of 2024, According To ExpertsMarch 26, 2024 | lse.co.ukOptiBiotix Health raises GBP1.4 million to invest in "driving sales"February 28, 2024 | msn.comYork's OptiBiotix Health grows sales as it eyes US and Asia opportunitiesFebruary 27, 2024 | forbes.comBest CBD Gummies For Sleep Of 2024January 22, 2024 | lse.co.ukOptiBiotix Health Share ChatJanuary 18, 2024 | forbes.comBest Pre-Workouts Of 2024, According To ExpertsDecember 19, 2023 | morningstar.comOptiBiotix Health PLC OPTINovember 28, 2023 | lse.co.ukTRADING UPDATES: Scancell trial progresses; OptiBiotix inks new dealNovember 1, 2023 | lse.co.ukOptiBiotix says market still "volatile" but partner sales improvingOctober 23, 2023 | marketwatch.comOptiBiotix Health Agrees With Tata Chemicals to Use Fossence IngredientSeptember 20, 2023 | forbes.comAetna Medicare Advantage Review (2023)September 8, 2023 | uk.news.yahoo.comYork Bio-tech firm reports record online salesAugust 29, 2023 | msn.comOptiBiotix Health achieved its highest ever own brand online sales in JulyJune 29, 2023 | finance.yahoo.comOptiBiotix Health Full Year 2022 Earnings: EPS: UK£0.029 (vs UK£0.071 in FY 2021)May 17, 2023 | forbes.comWhat Is The Mediterranean Diet? Benefits, Risks And MoreApril 29, 2023 | marketwatch.comHome Meal Replacement (HMR) Market | Report By 2023-2030February 23, 2023 | lse.co.ukOptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiaryFebruary 18, 2023 | marketwatch.comHome Meal Replacement (HMR) Market 2023 : Global Industry Share, Key Dynamics and Forecast to 2028January 15, 2023 | marketwatch.comHome Meal Replacement (HMR) Market 2023 : Industry Analysis, Opportunities, Technology, Top Players and Growth Forecast 2028December 5, 2022 | marketwatch.comOptiBiotix Health Shares Fall on Discounted Fund RaisingOctober 24, 2022 | lse.co.ukOptiBiotix Health gets approval to sell products in Saudi ArabiaAugust 30, 2022 | nz.finance.yahoo.comPrebiotic Ingredients Market Size to Reach Around USD 20.78 Bn by 2030August 24, 2022 | lse.co.ukOptiBiotix shares plunge on "very difficult trading" in half-yearAugust 24, 2022 | marketwatch.comOptiBiotix Health Sees 1H Sales Below Expectations; Shares DiveAugust 23, 2022 | fool.co.ukOptiBiotix HealthJuly 18, 2022 | benzinga.comOptiBiotix Health (OTC:OPBXF), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comOptiBiotix Health (OTC:OPBXF), Analyst Ratings, Price Targets, PredictionsJuly 11, 2022 | marketwatch.comOptiBiotix Signs Selling, Manufacturing Joint Development Deal With FirmenichJune 28, 2022 | marketwatch.comOptiBiotix 2021 Pretax Profit Rose on Higher Revenue; Says Making Good Progress in 2022June 20, 2022 | lse.co.ukOptiBiotix welcomes Steen Anderson as new CEO of ProBiotix spin-offMay 31, 2022 | lse.co.ukLaunch of cholesterol reducing yoghurtApril 21, 2022 | msn.comPM Boris Johnson announces new deals worth £1bn on India visitMarch 31, 2022 | proactiveinvestors.comOptiBiotix Health CEO Stephen O’Hara explains why it makes sense to spin off ProBiotix HealthMarch 31, 2022 | proactiveinvestors.com.auOptiBiotix Health demerger complete as ProBiotix Health debuts on Aquis exchangeFebruary 28, 2022 | lse.co.ukTRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividendFebruary 28, 2022 | marketwatch.comOptiBiotix 2021 Sales, Gross Profit Rose as It Expanded to New RegionsFebruary 9, 2022 | marketwatch.comOptiBiotix Plans Territory, Product Line Expansions in 2022January 30, 2022 | proactiveinvestors.com.auFive at Five: Another FTSE 100 fall, rate rise coming, Optibiotix readies new generation of products, Biden turns on crypto and Tesla tanksJanuary 18, 2022 | proactiveinvestors.comOptiBiotix Health says latest study supports case for LPLDL as an alternative to statinsJanuary 11, 2022 | msn.comSMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentum with next gen microbiome-focused developmentsJanuary 11, 2022 | msn.comSMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentumJanuary 5, 2022 | lse.co.ukOptiBiotix receives British Retail Consortium accreditationDecember 1, 2021 | marketwatch.comOptiBiotix Launches New Product, Signs License for GBP1 Mln a YearNovember 21, 2021 | mirror.co.ukTory MPs including Sajid Javid benefit from links to private health firmsNovember 8, 2021 | news.yahoo.comThe London MPs who declared more than £10k from their second jobsSeptember 30, 2021 | au.finance.yahoo.comDigestive Health Products Market Size Hit US$ 72.5 Bn by 2030September 28, 2021 | markets.businessinsider.comOptiBiotix Health : Investor update Get OptiBiotix Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address #1 election stock (Ad)I’ve found the number one company to buy… Before either Trump or Biden wins in November. It all has to do with an overlooked executive order that Trump signed just days before leaving office… and that Biden has quietly hijacked for his own political power. For the full story, click here. OPTI Media Mentions By Week OPTI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPTI News Sentiment▼-0.260.58▲Average Medical News Sentiment OPTI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPTI Articles This Week▼10▲OPTI Articles Average Week Get OptiBiotix Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Oncimmune News Destiny Pharma News Hemogenyx Pharmaceuticals News Ondine Biomedical News OKYO Pharma News Synairgen News Sareum News BiVictriX Therapeutics News ImmuPharma News C4X Discovery News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OPTI) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon to Transform U.S. Economy? Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
